| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | austocystin d | CTRPv2 | pan-cancer | AAC | -0.0065 | 0.9 |
| mRNA | selumetinib:tretinoin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0062 | 0.9 |
| mRNA | temsirolimus | GDSC1000 | pan-cancer | AAC | -0.0063 | 0.9 |
| mRNA | SB 505124 | GDSC1000 | pan-cancer | AAC | -0.0063 | 0.9 |
| mRNA | Cisplatin | GDSC1000 | pan-cancer | AAC | -0.0062 | 0.9 |
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | -0.0076 | 0.9 |
| mRNA | blebbistatin | CTRPv2 | pan-cancer | AAC | -0.012 | 0.9 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | 0.0052 | 0.9 |
| mRNA | Panobinostat | FIMM | pan-cancer | AAC | -0.037 | 0.9 |
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | -0.006 | 0.9 |